Nangona i-anti-depressants ingasetyenziselwa ukhathaza uxhalaba, yinto enokuthi igalelo linye lala mayeza. Oku kunokudideka, ingakumbi ukuba uphathwa ngempumelelo ngenxa yokudandatheka kodwa uqale uziva uxhalabile ngexesha elinye. Kukho isibalo sezizathu ezinokwenzeka kule nto, nangona kukulungele ukuxoxa ngeengxaki zakho kunye nogqirha wakho.
Ukuxhatshazwa nokuxhalabisa
Iingxaki zokuxhatshazwa ngokuqhelekileyo zisetyenziselwa ukuphatha iingxaki zengxakini, ngokukodwa ukuxhalaba kunye nokuphazamiseka kokuphazamiseka, kunye nokudandatheka. Kwabanye abantu, ukudandatheka kunye neengxaki zokuxhalabisa kunokubambisana. Ngokomzekelo, uphando oluthile lufumene ukuba malunga neepesenti ezingama-67 zabantu abanexinzelelo yokudandatheka nabo banenkinga yokuxhalabisa.
Xa iimeko ezimbini zikhona ngexesha elifanayo, oku kwaziwa ngokuba yi- comorbidity . Akuqhelekanga kwaye abaphandi baqhubeka bejonga indlela abaxinzelelweyo ngayo abanokukuncedisa zombini iindidi zeemeko, kubandakanywa ikhonkco phakathi kweengxaki kunye ne-neurotransmitter serotonin.
Syndrome yokuSebenza
Ngamanye amaxesha, izidalwa ezixinzelelekileyo zingaphinde zenze iimvakalelo zokuxhalaba kunye nokunyuka njengomphumo wecala. Esi siphumo, ngamanye amaxesha esibizwa ngokuba yi-activation syndrome, ngokuqhelekileyo ivela kwiintsuku zokuqala zonyango. Kwisifundo esithile, iipesenti ezingama-31 zabantu abazange bathathe i-antidepressants phambi kwe-activation syndrome.
Ukuphononongwa ngokuchanekileyo kwezifundo ezininzi kwathatha eli nyathelo. Kulo, abaphandi baqhathanisa iqondo lokuhlutha / uxinzelelo lweengxaki phakathi kweentlobo ezahlukeneyo zokuxhatshazwa. Iziphumo zihluka kakhulu, kunye naphi na kwi-4 ukuya kuma-65 ekhulwini labantu abasandula ukuchazwa ngabadandathelisi abanolu phulo.
Ngokuqhelekileyo, impembelelo yecala ithambile kwaye ixeshana, idibanisa njengokuba umntu ulungelelanisa amachiza amatsha. I-syndrome esebenzayo inokuthi ibandakanye iimpawu ezinjengokuphazamiseka, ukusabalalisa, ukuthukuthela, ukugwenxa, ukunyanzelisa, nokungazinzi.
Ukuxinezeleka nokuzibulala
Ukongezelela, kukho ubudlelwane obunzima phakathi kweempawu ezifana ne- hypomania okanye imania . Oku kungonakalisa ukudandatheka okanye iingcamango zokuzibulala-esinye isiphumo esingaqhelekanga sonyango lokuxhatshazela-kunye nobukho be-activation syndrome.
Abantwana, abaselula, nabaselula abasenokuba nzima ukuphuhlisa imiphumo eyingozi yokukhathazeka nokuzibulala. Ngo-2007, i-US Food and Drug Administration (FDA) yahlaziya isilumkiso sebhokisi emnyama efunekayo kuzo zonke iintsholongwane. Ulwazi olutsha luquka umngcipheko owongeziweyo wokuphuhlisa iingcinga zokuzibulala kwaye unxusa ngexesha lokuqala unyango.
I-FDA iphinda icebise ukuba nayiphi na umntwana, umntwana okanye umntwana osemdala oqala unyango kunye noxinzelelo lwe-anti-depressant ukuba aqwalaselwe ngokucophelela nangayiphi na imiqondiso yenguqu engaqhelekanga yokuziphatha, ukuxinezeleka kokudakumba okanye ukuzibulala. Uncedo kufuneka lufunwe ngokukhawuleza ukuba kukho na le nto iyenzekayo.
Into onokuyenza
Ukuba uvakalelwa kukuba u-anti-depressant ukwandisa uxhalaba lwakho, thetha nodokotela wakho malunga nalo.
Kukho iindlela ezahlukeneyo ezingayithatha ukulwa nale mpembelelo. Ngokomzekelo, banokunciphisa umthamo wakho, ukutshintshela kumachiza ahlukeneyo, okanye ubeke elinye iyeza ukuba lichasane nalo.
Akucetyiswa ukuba uyeke ukuthatha i-antidepressant yakho ngaphandle kokubonisana nodokotela wakho kuqala. Ukuyeka imithi yakho ngokukhawuleza kunokudala iingxaki zaso, kuquka iimpawu ezinjengamaqhwa emisipha, ukukhathala, isisu esisisigxina, kunye nesisu. Kananjalo ubeka ingozi yokuba uxinzelelo lwakho luya kubuya okanye lube nzima.
ILizwi
Xa uqala ukuthatha i-anti-depressant entsha, kungathatha ixesha lokuba umzimba wakho ulungelelanise.
Wonke umntu uhlukile, yingako kubalulekile ukunxibelelana nodokotela wakho malunga nayiphi na imiphumo ebangela ukuba uvale, kuquka ukunyuka koxhala. Okona kubaluleke ukuba, xa ufumana iingcinga zokuzibulala, zuza uncedo lwezokwelapha ngokukhawuleza.
> Imithombo:
> Albert PR, Vahid-Ansari F, uLuckhart C. Serotonin-Prefrontal I-Cortical Circuitry kwixhala kunye neengxaki zengcinezelo Iiphenotypes: Inxaxheba ebalulekileyo ye-Pre-ne-Post-Synaptic 5-HT1a I-Receiver Expression. Imida kwiNzululwazi yokuziphatha. 2014; 8: 199. i-doi: 10.3389 / fnbeh.2014.00199.
> Harada T, et al. Isiganeko kunye nokuqikelela kwe-activation syndrome eyenziwa ngabaxinzelelo. Ukuxinezeleka nokuxhalabisa . 2008; 25 (12): 1014-9. i-doi: 10.1002 / da.20438.
> Lamers F, et al. Ukuxhatshazwa kwamaphetheni okuxhalabisa kunye neengxaki ezixinzeleleyo kwiSifundo esiPhakamileyo esikhulu: i-Netherlands Study of Depress and Concern (NESDA). Umbhalo we-Clinical Psychiatry . 2011; 72 (3): 341-8. i-doi: 10.4088 / JCP.10m06176blu.
> Sinclair L, et al. I-Anti-depressant-Induduzo Yokuxhaswa / Isifo Sokuxhalabisa: Ukuhlaziywa koHlolo. I-British Journal ye-Psychiatry . 2009; 194: 483-490. i-doi: 10.1192 / bjp.bp.107.048371.